FRTY vs. BOUT

Last updated Jun 25, 2026

FRTY (Alger Mid Cap 40 ETF) and BOUT (Innovator IBD Breakout Opportunities ETF) are both Mid Cap Growth Equities funds. FRTY is actively managed, while BOUT is passively managed. Over the past 5 years, FRTY returned 3.68%/yr vs 8.26%/yr for BOUT. A 0.70 correlation means they provide meaningful diversification when combined. FRTY charges 0.60%/yr vs 0.80%/yr for BOUT.

Performance

FRTY vs. BOUT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alger Mid Cap 40 ETF (FRTY) and Innovator IBD Breakout Opportunities ETF (BOUT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, FRTY achieves a 11.84% return, which is significantly lower than BOUT's 31.43% return.

FRTY

• 1D: 0.28%
• 1M: 5.92%
• YTD: 11.84%
• 6M: 10.13%
• 1Y: 22.76%
• 3Y*: 23.80%
• 5Y*: 3.68%
• 10Y*: —

BOUT

• 1D: -0.34%
• 1M: 3.21%
• YTD: 31.43%
• 6M: 27.80%
• 1Y: 32.74%
• 3Y*: 16.76%
• 5Y*: 8.26%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

FRTY vs. BOUT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
FRTY Alger Mid Cap 40 ETF	11.84%	12.82%	38.86%	16.81%	-42.23%	2.46%
BOUT Innovator IBD Breakout Opportunities ETF	31.43%	-6.77%	18.82%	13.27%	-22.60%	14.09%

Correlation

The correlation between FRTY and BOUT is 0.75, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.75
Correlation (3Y) Calculated over the trailing 3-year period	0.73
Correlation (5Y) Calculated over the trailing 5-year period	0.70
Correlation (All Time) Calculated using the full available price history since Mar 1, 2021	0.70

The correlation between FRTY and BOUT has been stable across timeframes, ranging from 0.70 to 0.75 - a consistent structural relationship.

FRTY vs. BOUT - Sectors Allocation Comparison

Sectors	FRTY	BOUT
Technology	32.4%	33.0%
Industrials	26.0%	3.2%
Healthcare	20.0%	6.5%
Communication Services	10.7%	3.3%
Energy	6.6%	4.0%
Financial Services	5.2%	18.3%
Consumer Cyclical	4.0%	10.8%
Utilities	1.7%	7.0%
Consumer Defensive	1.0%	4.8%
Basic Materials	0.0%	12.3%
Real Estate	-	3.9%

Return for Risk

FRTY vs. BOUT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FRTY

FRTY Risk / Return Rank: 25
FRTY Sharpe Ratio Rank: 26
FRTY Sortino Ratio Rank: 25
FRTY Omega Ratio Rank: 24
FRTY Calmar Ratio Rank: 26
FRTY Martin Ratio Rank: 25

BOUT

BOUT Risk / Return Rank: 52
BOUT Sharpe Ratio Rank: 49
BOUT Sortino Ratio Rank: 46
BOUT Omega Ratio Rank: 45
BOUT Calmar Ratio Rank: 64
BOUT Martin Ratio Rank: 54

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FRTY vs. BOUT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Alger Mid Cap 40 ETF (FRTY) and Innovator IBD Breakout Opportunities ETF (BOUT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	FRTY	BOUT	Difference
Sharpe ratio: Return per unit of total volatility	0.85	1.50	-0.65
Sortino ratio: Return per unit of downside risk	1.28	2.07	-0.79
Omega ratio: Gain probability vs. loss probability	1.16	1.26	-0.11
Calmar ratio: Return relative to maximum drawdown	1.16	2.80	-1.64
Martin ratio: Return relative to average drawdown	2.99	8.27	-5.28

FRTY vs. BOUT - Sharpe Ratio Comparison

The current FRTY Sharpe Ratio is 0.85, which is lower than the BOUT Sharpe Ratio of 1.50. The chart below compares the historical Sharpe Ratios of FRTY and BOUT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

FRTY vs. BOUT - Drawdown Comparison

The maximum FRTY drawdown since its inception was -53.15%, which is greater than BOUT's maximum drawdown of -36.98%. Use the drawdown chart below to compare losses from any high point for FRTY and BOUT.

Drawdown Indicators

	FRTY	BOUT	Difference
Max Drawdown Largest peak-to-trough decline	-53.15%	-36.98%	-16.17%
Max Drawdown (1Y) Largest decline over 1 year	-19.75%	-11.76%	-7.99%
Max Drawdown (3Y) Largest decline over 3 years	-31.48%	-25.31%	-6.17%
Max Drawdown (5Y) Largest decline over 5 years	-53.15%	-28.28%	-24.87%
Current Drawdown Current decline from peak	-2.58%	-2.24%	-0.34%
Average Drawdown Average peak-to-trough decline	-27.69%	-12.29%	-15.40%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.64%	3.97%	+3.67%

Volatility

FRTY vs. BOUT - Volatility Comparison

Alger Mid Cap 40 ETF (FRTY) has a higher volatility of 10.11% compared to Innovator IBD Breakout Opportunities ETF (BOUT) at 8.25%. This indicates that FRTY's price experiences larger fluctuations and is considered to be riskier than BOUT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FRTY	BOUT	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.11%	8.25%	+1.86%
Volatility (6M) Calculated over the trailing 6-month period	19.68%	17.20%	+2.48%
Volatility (1Y) Calculated over the trailing 1-year period	26.95%	21.91%	+5.04%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	27.43%	19.70%	+7.73%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.23%	23.00%	+4.23%

FRTY vs. BOUT - Expense Ratio Comparison

FRTY has a 0.60% expense ratio, which is lower than BOUT's 0.80% expense ratio.

Dividends

FRTY vs. BOUT - Dividend Comparison

FRTY's dividend yield for the trailing twelve months is around 0.17%, less than BOUT's 0.26% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018
BOUT Innovator IBD Breakout Opportunities ETF	0.26%	0.34%	0.60%	1.32%	1.35%	0.00%	0.00%	0.00%	0.22%
FRTY Alger Mid Cap 40 ETF	0.17%	0.19%	0.10%	0.00%	0.00%	5.35%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both FRTY and BOUT in my portfolio?

FRTY and BOUT have a correlation of 0.75, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, FRTY or BOUT?

FRTY has higher volatility (10.11%) compared to BOUT (8.25%). In terms of maximum drawdown, FRTY dropped -53.15% vs BOUT's -36.98%.

Which ETF is better, FRTY or BOUT?

On 5-year performance, BOUT leads with 8.26% vs 3.68% for FRTY. On fees, FRTY is cheaper at 0.60% per year. On volatility, BOUT has been the lower-risk option at 8.25%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, FRTY or BOUT?

Over the 5-year period, BOUT has performed better with a 8.26% return vs 3.68%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, FRTY or BOUT?

FRTY is cheaper with a 0.60% expense ratio, compared with 0.80% for BOUT.

Which ETF pays a higher dividend yield, FRTY or BOUT?

BOUT has the higher dividend yield at 0.26%, compared with 0.17% for FRTY.

What is the main difference between FRTY and BOUT?

They also come from different issuers: Alger Group Holdings LLC and Innovator. Their fees differ too: 0.60% for FRTY and 0.80% for BOUT.

Which has better risk-adjusted returns?

BOUT currently has the higher Sharpe Ratio (1.50 vs 0.85), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.